Latest news with #AntiqueStockBrokingLimited
&w=3840&q=100)
Business Standard
29-06-2025
- Business
- Business Standard
Indian pharma eyes US gains as $63.7 bn patent cliff nears: Analysts
The Indian pharmaceutical industry is poised to benefit from a major wave of patent expiries in the US, with small-molecule drugs worth $63.7 billion expected to go off-patent between 2025 and 2029—a 65 per cent increase over the previous five years. Combined with a broader Loss of Exclusivity (LoE) opportunity across the US and EU projected to reach $180 billion by 2035, this marks a significant opening for Indian drugmakers, according to a report by Antique Stock Broking Limited. This shift is expected to spur a rise in generic launches, particularly benefiting Indian players with emerging US operations and expertise in complex generics. Firms such as Alembic Pharmaceuticals and Shilpa Medicare, which have smaller US footprints, and larger players like Cipla and Lupin, which have invested early in differentiated products such as injectables and respiratory therapies, are seen as well positioned to gain market share. With global majors like Teva, Viatris and Sandoz having closed dozens of manufacturing sites since 2018, Indian companies are stepping in to fill the supply gap. However, the opportunity is unfolding amid growing strategic discipline. Filings of Abbreviated New Drug Applications (ANDAs) in the US declined 25 per cent year-on-year. FY25 filings are projected to close around 550—down from 740 in FY24 and 857 in FY22. This signals a pivot from volume to portfolio quality, regulatory compliance and margin protection. Commenting on this shift, Nilaya Varma, Group CEO and Co-founder of Primus Partners, said, 'India's pharma exports have grown from $15 billion in 2013–14 to nearly $28 billion in a decade. With 750+ USFDA-approved plants and rising strength in complex generics and biosimilars, India is primed to lead the next wave of affordable, high-quality medicines. Tapping the $180 billion LoE opportunity will require continued focus on compliance and quality systems.' Regulatory headwinds are also easing. The share of US FDA inspections resulting in Official Action Indicated (OAI) for Indian firms has fallen from 19 per cent in 2013 to 9 per cent in 2023. Companies like Cipla are further de-risking their US supply chains by adopting multi-site manufacturing and digital quality systems. Cipla, which holds a robust US portfolio of 284 ANDA and NDA filings—175 of which are approved and 73 under review—is focusing on commercialisation-ready products, including PEPFAR-approved generics. The company is betting on complex respiratory and injectable therapies to drive growth. Pharma major Lupin, which continues to benefit globally from its blockbuster autoimmune biologic Etanercept, plans to finalise its US commercialisation strategy closer to the drug's 2029 patent expiry. Meanwhile, Sun Pharma, despite offering a conservative FY26 outlook amid global macro uncertainties, is expanding its oncology pipeline. Its recently acquired UNLOXCYT (cosibelimab) is expected to significantly contribute to US revenues. The company noted that Keytruda's upcoming patent expiry was already factored into the acquisition. UNLOXCYT targets only one of Keytruda's multiple indications, and Sun remains confident in its potential to become a meaningful contributor to its US specialty business. In parallel, Sun is also strengthening its immunotherapy portfolio through a global licensing agreement with Philogen.
India Gazette
25-06-2025
- Business
- India Gazette
Falling commodity prices expected to boost profits of FMCG companies: Report
New Delhi [India], June 25 (ANI): Fast-Moving Consumer Goods (FMCG) companies in India are likely to see an improvement in their profit margins in the first quarter of FY26, which is attributed to a broad-based decline in the prices of key agricultural and packaging commodities, according to a report by Antique Stock Broking Limited. Prices of several essential inputs have eased, which could benefit major players. During Q1FY26, most agri-commodity prices fell when compared to Q4FY25. This trend points to a moderation in year-on-year (YoY) inflation and offers relief to FMCG manufacturers, who have been grappling with high input costs over the past few quarters. Wheat, a staple raw material for several FMCG products, saw a price correction of 13 per cent on a quarter-on-quarter (QoQ) basis. Barley prices also dropped by 13 per cent QoQ, although they were still up 10 per cent YoY. A sharp decline in palm oil prices -- down 16 per cent QoQ -- was particularly notable, especially after the government reduced import duties on the product by 10 per cent at the end of May 2025. This move is expected to bring further downward pressure on prices in the near costs also trended lower during the quarter. High-Density Polyethylene (HDPE), used extensively in packaging, remained soft. Crude-based packaging inputs witnessed only a marginal 3 per cent increase in prices, a manageable rise for most companies. Among dairy inputs, Skimmed Milk Powder (SMP) rose slightly by 4 per cent QoQ, and liquid milk increased by just 1 per cent QoQ, marking a relatively stable pricing trend in dairy, which is crucial for food and beverage manufacturers. However, not all commodities followed this deflationary trend. Copra, a key input for coconut-based products and edible oils, emerged as an outlier. Overall, except for dairy and select inputs like copra and LLP, most commodity prices declined in the range of 2 per cent to 14 per cent. This downward trend is expected to provide significant cost savings for FMCG firms, allowing them to either protect their margins or pass on benefits to consumers in the form of price reductions. (ANI)
Canada News.Net
23-06-2025
- Business
- Canada News.Net
Corporate travel, MICE, live events to boost operating performance of hospitality industry: Report
New Delhi [India], June 22 (ANI): The hospitality industry will maintain strong operating performance in the near term, supported by strong corporate travel, MICE activity, live events, and a buoyant wedding season, according to a report by Antique Stock Broking Limited. As per the report, medium-term growth of the industry is expected to be driven by sustained demand-supply imbalances and a healthy pipeline of new hotel additions. The hospitality sector has significantly benefited by the increased demand from the Meetings, Incentives, Conferences, and Exhibitions (MICE) sector. 'The hospitality industry should continue to deliver strong operating performance in the near term aided by strong corporate demand, MICE, live events, and the wedding business,' the report added. This growth has resulted in a sharp increase in Average Room Rates (ARRs) and occupancy levels. The sector is expected to be in a long-term upcycle, supported by shifts in consumer preferences, rising disposable incomes, and increased travel spending, say several experts. In the fourth quarter, the large hotel firms reported strong demand, and they highlighted strong demand visibility for 1Q and FY26 driven by large-scale events, concerts, conferences and weddings. The hotel industry executives anticipate the strong rate growth momentum to continue in the near term, as highlighted in the report. Several reports say that the overall industry is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.4 per cent from FY24 to FY29, outpacing supply growth at 9 per cent. India's tourism sector, rich in heritage, culture, and diversity, is emerging as a global favourite and a key driver of economic growth. Recognising its potential for employment-led development, the Union Budget 2025-26 has allocated Rs 2541.06 crore to enhance infrastructure, skill development, and travel facilitation. A major initiative includes developing 50 top tourist destinations in partnership with states through a challenge mode, ensuring world-class facilities and connectivity. As per the government data, the tourism sector's contribution to GDP regained the pre-pandemic level of 5 per cent in FY23. The tourism sector created 7.6 crore jobs in FY23. International tourist arrivals (ITAs) in India have rebounded to pre-pandemic level in 2023. The share of India's ITAs in World ITAs stands at 1.45 per cent in 2023. Foreign exchange earnings through tourism were 28 billion USD. India received 1.8 per cent of world tourism receipts and attained a rank of 14th worldwide in world tourism receipts during 2023. (ANI)
India Gazette
22-06-2025
- Business
- India Gazette
Corporate travel, MICE, live events to boost operating performance of hospitality industry: Report
New Delhi [India], June 22 (ANI): The hospitality industry will maintain strong operating performance in the near term, supported by strong corporate travel, MICE activity, live events, and a buoyant wedding season, according to a report by Antique Stock Broking Limited. As per the report, medium-term growth of the industry is expected to be driven by sustained demand-supply imbalances and a healthy pipeline of new hotel additions. The hospitality sector has significantly benefited by the increased demand from the Meetings, Incentives, Conferences, and Exhibitions (MICE) sector. 'The hospitality industry should continue to deliver strong operating performance in the near term aided by strong corporate demand, MICE, live events, and the wedding business,' the report added. This growth has resulted in a sharp increase in Average Room Rates (ARRs) and occupancy levels. The sector is expected to be in a long-term upcycle, supported by shifts in consumer preferences, rising disposable incomes, and increased travel spending, say several experts. In the fourth quarter, the large hotel firms reported strong demand, and they highlighted strong demand visibility for 1Q and FY26 driven by large-scale events, concerts, conferences and weddings. The hotel industry executives anticipate the strong rate growth momentum to continue in the near term, as highlighted in the report. Several reports say that the overall industry is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.4 per cent from FY24 to FY29, outpacing supply growth at 9 per cent. India's tourism sector, rich in heritage, culture, and diversity, is emerging as a global favourite and a key driver of economic growth. Recognising its potential for employment-led development, the Union Budget 2025-26 has allocated Rs 2541.06 crore to enhance infrastructure, skill development, and travel facilitation. A major initiative includes developing 50 top tourist destinations in partnership with states through a challenge mode, ensuring world-class facilities and connectivity. As per the government data, the tourism sector's contribution to GDP regained the pre-pandemic level of 5 per cent in FY23. The tourism sector created 7.6 crore jobs in FY23. International tourist arrivals (ITAs) in India have rebounded to pre-pandemic level in 2023. The share of India's ITAs in World ITAs stands at 1.45 per cent in 2023. Foreign exchange earnings through tourism were 28 billion USD. India received 1.8 per cent of world tourism receipts and attained a rank of 14th worldwide in world tourism receipts during 2023. (ANI)
